Targeting Oncogenic N-MYC Complexes in High-Risk Neuroblastoma |
The Regents of the University of California San Francisco / Bo Qiu, MD/PhD |
Young Investigator Grants |
2023 |
California |
Stapled Oncolytic Peptides for Treatment-Resistant Pediatric Leukemias |
Dana-Farber Cancer Institute / Loren Walensky, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital / Dirk Loeffler, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Tennessee |
Desmoplastic Small Round Cell Tumors: Investigation of its Pathogenesis and Development of Novel Therapies |
Memorial Sloan-Kettering Cancer Center / Andrea Ventura, MD, PhD |
Innovation Grants |
2023 |
New York |
A Genomics Driven Pluripotent Stem Cell Model of Infant Lymphoblastic Leukemia |
Children's Mercy Hospital Kansas City / Meagan Vacek, DO |
Catalyst Grants |
2023 |
Missouri |
In Situ CD19.CAR-T Generation Using TRIDENT System for Pediatric B Cell Malignancies |
Baylor College of Medicine / Masataka Suzuki, PhD |
Innovation Grants |
2023 |
Texas |
Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma |
Duke University / Zachary Reitman, MD/PhD |
'A' Award Grants |
2023 |
North Carolina |
Pre-Targeted Radioimmunotherapy for Desmoplastic Small Round Cell Tumors |
Memorial Sloan-Kettering Cancer Center / Madelyn Espinosa-Cotton, PhD |
Young Investigator Grants |
2023 |
New York |
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
Identifying Therapeutic Vulnerabilities in Pediatric AML through Investigation of the MECOM Transcriptional Network |
Boston Children’s Hospital / Richard Voit, MD/PhD |
Young Investigator Grants |
2023 |
Massachusetts |